Cabeza Montilla, Laura Author
Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs
- Prados J.
- Melguizo C.
- Ortiz R.
- Perazzoli G.
- Cabeza L.
- Álvarez P.
- Rodriguez-Serrano F.
- Aranega A.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY - 29/10/2013
- SJR Quartile: Q1
- JCR Impact Factor: 2.939 (2013)
- CiteScore: 3.5 (2020)
- SJR: 1.122 (2013
- SNIP: 0.836 (2013
- JCR 5-year Impact Factor: 3.37
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)
- Scopus
- ORCID
- Web of Science
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer
- Clares B.
- Biedma-Ortiz R.
- Sáez-Fernández E.
- Prados J.
- Melguizo C.
- Cabeza L.
- Ortiz R.
- Arias J.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS - 1/11/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.245 (2013)
- CiteScore: 9 (2020)
- SJR: 1.566 (2013
- SNIP: 1.721 (2013
- JCR 5-year Impact Factor: 4.737
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
- Prados, Jose
- Melguizo, Consolacion
- Perazzoli, Gloria
- Cabeza, Laura
- Carrasco, Esther
- Oliver, Jaime
- Jimenez-Luna, Cristina
- Leiva, Maria C.
- Ortiz, Raul
- Alvarez, Pablo J.
- Aranega, Antonia
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY - 1/1/2014
- SJR Quartile: Q1
- JCR Impact Factor: 4.295 (2014)
- CiteScore: 5.1 (2020)
- SJR: 1.092 (2014
- SNIP: 0.837 (2014
- JCR 5-year Impact Factor: 2.909
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)
- Scopus
- ORCID
- Web of Science
Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
- Perazzoli G.
- Prados J.
- Ortiz R.
- Caba O.
- Cabeza L.
- Berdasco M.
- Gónzalez B.
- Melguizo C.
PLOS ONE - 8/10/2015
- SJR Quartile: Q1
- JCR Impact Factor: 3.057 (null)
- CiteScore: 2.97 (2018)
- SJR: 1.427 (2015
- SNIP: 1.149 (2015
- JCR 5-year Impact Factor: 3.535
- JCR Categories: MULTIDISCIPLINARY SCIENCES
- SJR Categories: Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles
DRUG DESIGN DEVELOPMENT AND THERAPY - 14/12/2015
- SJR Quartile: Q1
- JCR Impact Factor: 2.881 (2015)
- CiteScore: 3.27 (2018)
- SJR: 0.982 (2015
- SNIP: 0.978 (2015
- JCR 5-year Impact Factor: 2.962
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)
- Scopus
- ORCID
- Web of Science
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles
- Cabeza L.
- Ortiz R.
- Arias J.
- Prados J.
- Martínez M.
- Entrena J.
- Luque R.
- Melguizo C.
INTERNATIONAL JOURNAL OF NANOMEDICINE - 13/2/2015
- SJR Quartile: Q1
- JCR Impact Factor: 4.32 (2015)
- CiteScore: 9.2 (2020)
- SJR: 1.323 (2015
- SNIP: 1.366 (2015
- JCR 5-year Impact Factor: 5.034
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Organic Chemistry (Q1)
- Scopus
- ORCID
- Web of Science
Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer
- Ortiz R.
- Cabeza L.
- Arias J.
- Melguizo C.
- Álvarez P.
- Vélez C.
- Clares B.
- Áranega A.
- Prados J.
AAPS JOURNAL - 24/7/2015
- SJR Quartile: Q1
- JCR Impact Factor: 3.819 (2015)
- CiteScore: 6.8 (2020)
- SJR: 1.295 (2015
- SNIP: 1.421 (2015
- JCR 5-year Impact Factor: 4.618
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Nanopartículas Magnéticas en el Diagnóstico y Tratamiento del Cáncer
- Kevin Doello
- Laura Cabeza
- Raul Ortiz
- José Luis Arias Mediano
- Consolación Melguizo
- José Carlos Prados
Actualidad médica - 2015
- Dialnet
Generation of miR-21 sponges in lung cancer treatment
- Rama A.
- Hernández R.
- Jiménez J.
- Leiva M.
- Jiménez-Luna C.
- Cabeza L.
- Perazzoli G.
- Prados J.
JOURNAL OF THORACIC ONCOLOGY - 1/4/2016
- SJR Quartile: Q1
- JCR Impact Factor: 6.595 (2016)
- CiteScore: 20 (2020)
- SJR: 2.754 (2016
- SNIP: 1.756 (2016
- JCR 5-year Impact Factor: 5.983
- JCR Categories: RESPIRATORY SYSTEM
- SJR Categories: Medicine (miscellaneous) (Q1); Oncology (Q1); Pulmonary and Respiratory Medicine (Q1)
Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer
- Rama A.
- Jimenez-Lopez J.
- Cabeza L.
- Jimenez-Luna C.
- Leiva M.
- Perazzoli G.
- Hernandez R.
- Zafra I.
- Ortiz R.
- Melguizo C.
- Prados J.
CURRENT DRUG DELIVERY - 1/9/2016
10.2174/1567201813666151203232852
- SJR Quartile: Q2
- JCR Impact Factor: 2.516 (2016)
- CiteScore: 3.6 (2020)
- SJR: 0.504 (2016
- SNIP: 0.747 (2016
- JCR 5-year Impact Factor: 2.338
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q2)
- Scopus
- ORCID
- Web of Science
Mejora de la actividad antitumoral de agentes citotóxicos mediante el uso de nanoplataformas poliméricas: aplicación en cáncer de colon, mama y pulmón
- Laura Cabeza
- Consolación Melguizo
- José Carlos Prados Salazar
- Raul Ortiz Quesada
2017
- Dialnet
Combinaciones terapéuticas y sus ventajas en el tratamiento del síndrome de dolor miofascial
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Acercamiento multidisciplinar a la salud: Volumen IV - 2019
- Dialnet
Efectos del trabajo a turnos en enfermeras del servicio de urgencias hospitalarias entre 55 y 65 años en las etapas menopausia y post-menopausia
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Investigación en salud y envejecimiento: Volumen VI - 2019
- Dialnet
This author has no conferences.
This author has no patents.
This author has no reports or other types of publications.
h index
Scopus: 14
Web of Science: 23
i10 index
Scopus: 19
Web of Science: 30
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador